Skip to main content
. Author manuscript; available in PMC: 2013 Mar 6.
Published in final edited form as: J Oral Maxillofac Surg. 2011 Jul 29;69(11):e324–e332. doi: 10.1016/j.joms.2011.03.059

Table 1.

Characteristics of Cryotherapy Subjects, Topical Minocycline Subjects, and Comparison Subjects (N = 206)

Cryotherapy Subjects
(n = 51)
Minocycline Subjects
(n = 63)
Comparison Subjects
(n = 92)
P Value
Gender [n (%)] .25
   M 27 (47) 25 (40) 36 (39)
   F 24 (53) 38 (60) 56 (61)
Race [n (%)]* .70
   White 38 (75) 55 (87) 71 (79)
   African American   4 (8)   2 (3) 10 (11)
   Other   9 (17)   6 (10)   9 (10)
Bone removal from both mandibular third molars [n (%)] 33 (65) 42 (62) 76 (83) .08
Mandibular occlusal plane position [n (%)] .04
   Third molars at plane 28 (62) 22 (37) 39 (52)
   Third molars below plane 17 (38) 37 (63) 36 (48)
Age at surgery [median (IQR)] (yr) 21 (19–24) 21 (19–23) 20 (18–24) .15
Total surgery time [median (IQR)] (min) 25 (20–40) 27 (20–40) 25 (18–30) .03
Surgeon’s assessment of degree of difficulty (4–28 possible) [median (IQR)] 14 (11–17) 14 (10–18) 12 (9–16) .09

NOTE. Cryotherapy subjects were included from 2005 to 2009 from 1 academic center. Topical minocycline subjects were included from 2003 to 2004 from 2 academic centers and 2 community practices. Comparison subjects were included from 2002 to 2006 from 3 academic centers and 2 community practices. Differences between comparison and treatment groups for demographic characteristics and extensiveness of surgery were assessed with χ2 or Cochran-Mantel-Haenszel row mean score tests. The level of significance was set at P < .05.

Abbreviation: IQR, interquartile range.

*

Missing 2 subjects in comparison group.

Missing 5 subjects in minocycline group.

Gelesko et al. Cryotherapy/Minocycline for Pain Control. J Oral Maxillofac Surg 2011.